Abstract
The jejunal absorption of indomethacin nanocapsules was studied using an in vivo infusion technique. Jejunal absorption of indomethacin from the nanocapsules was slightly delayed as compared to a commercial indomethacin solution. The plasma and jejunal mucosa indomethacin concentrations were similar in both cases. However, the nanocapsules protected the rat jejunum from the ulcerating effect of indomethacin, probably by avoiding direct contact of the free drug with the surface of the mucosa. The pharmacokinetic profile of indomethacin nanocapsule formulations was compared to a solution of free drug following oral administration of 5 mg/kg in rats; no difference in the mean concentration–time profiles of the drug was observed. Blood levels of thromboxane showed a sustained biological activity, over a period of 24 hr, of indomethacin-loaded nanocapsules, relative to the drug in solution, following oral administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
N. Al-Khouri Fallouh, L. Roblot-Treupel, H. Fessi, J.-P. Devissaguet, and F. Puisieux. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int. J. Pharm. 28:125–132 (1986).
J. F. Woodley. Liposomes for oral administration of drugs. CRC Crit. Rev. Ther. Drug Carrier Syst. 2:1–18 (1986).
M. Aprahamian, C. Michel, W. Humbert, J.-P. Devissaguet, and C. Damgé. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell 61:69–76 (1987).
H. Fessi, F. Puisieux, J.-P. Devissaguet, N. Ammoury, and S. Benita. Nanocapsule formation by interfacial deposition following solvent displacement. Int. J. Pharm. 55:R1–R4 (1989).
M.-M. Gallardo, L. Roblot-Treupel, J. Mahuteau, I. Genin, P. Couvreur, M. Plat, and F. Puisieux. Nanocapsules et nanosphères d'alkylcyanoacrylate, interactions principe actif/polymère. Proc., APGI, 5th Int. Conf. Pharm. Technol., Paris, 1989, Vol. IV, pp. 36–45.
E. C. Soehngen, E. Godin-Ostro, F. G. Fielder, R. S. Ginsberg, M. A. Slusher, and A. L. Weiner. Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulcerations when orally administered to rats. Arth. Rheum. 31:414–421 (1988).
M. E. Goldyne. Prostaglandins and other eicosanoids. In B. G. Katzung (ed.), Basic and Clinical Pharmacology, 2nd ed. Lange Medical, Los Altos, CA, 1984, pp. 217–226.
A. Drouet, M. LeDuff, R. LeVerge, and J.-P. Devissaguet. Application de la H.P.L.C. à l'étude de la clométacine chez l'homme. In J. M. Aiache and J. Hirtz (eds.), Proc. First Eur. Cong. Biopharm. Pharmacokin., Clermont-Ferrand, France, 1981, Vol. 2, pp. 502–507.
N. Ammoury, H. Fessi, J.-P. Devissaguet, F. Puisieux, and S. Benita. Physicochemical characterization of polymeric nanocapsules and in vitro release evaluation of indomethacin as a drug model. STP Pharm. 5 (10):647–651 (1989).
S. Benita, A. Rubinstein, Y. V. Palhek, and A. Reches. The influence of perfusion location and perfusate on the absorption of physostigmine from submicronized emulsion and solution in the rat intestine. Proc., APGI, 4th Int. Conf. Pharm. Technol., Paris, 1989, Vol. III, pp. 76–83.
P. Del Soldato, A. Meli, and G. Volterra. Influence of fasting and cimetidine on the relationship between ulcerogenic and anti-inflammatory properties of indomethacin. Br. J. Pharm. 67:33–37 (1979).
P. Pradelles, J. Grassi, and J. Maclouf. Enzyme immunoassays of eicosanoids using acetylcholinesterase as label: An alternative to radioimmunoassay. Anal. Chem. 57:1170–1173 (1985).
N. Ammoury, H. Fessi, J.-P. Devissaguet, F. Puisieux, and S. Benita. In vitro release pattern of indomethacin from poly (D,L-lactide) nanocapsules. J. Pharm. Sci. 79:763–767 (1990).
H. B. Hucker, A. G. Zacchei, S. V. Cox, D. A. Brodie, and N. H. R. Cantwell. Studies on the absorption, distribution and excretion of indomethacin in various species. J. Pharmacol. Exp. Ther. 153 (2):237–249 (1966).
V. Andrieu, M. Dubrasquet, H. Fessi, and J.-P. Devissaguet. Etude pharmacocinétique, biopharmaceutique et de tolérance digestive de dispersions colloïdales d'indométacine. Proc., APGI, 4th Int. Conf. Pharm. Technol., Paris, 1986, Vol. IV, pp. 166–174.
V. Andrieu, H. Fessi, M. Dubrasquet, J.-P. Devissaguet, F. Puisieux, and S. Benita. Pharmacokinetic evaluation of indomethacin nanocapsules. Drug Design Deliv. 4:295–302 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ammoury, N., Fessi, H., Devissaguet, JP. et al. Jejunal Absorption, Pharmacological Activity, and Pharmacokinetic Evaluation of Indomethacin-Loaded Poly(d,l-Lactide) and Poly(Isobutyl-Cyanoacrylate) Nanocapsules in Rats. Pharm Res 8, 101–105 (1991). https://doi.org/10.1023/A:1015846810474
Issue Date:
DOI: https://doi.org/10.1023/A:1015846810474